[Remote] Medical Science Liaison - Oncology, Lake Michigan Region at Natera

United States

Natera Logo
Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Pharmaceuticals, BiotechnologyIndustries

Skills

Key technologies and capabilities for this role

Scientific PresentationRelationship BuildingKey Opinion Leader EngagementClinical Trial SupportScientific CommunicationHealthcare Provider CollaborationTravel Readiness

Questions & Answers

Common questions about this position

What is the salary range for the Medical Science Liaison position?

The salary range is $145,000 - $170,000 USD.

Is this a remote position, and what are the location requirements?

This is a remote position, but candidates must live within the assigned Lake Michigan region territory.

What qualifications and skills are required for this role?

A Master’s degree is required, with an advanced healthcare/scientific degree (Ph.D., Pharm.D, M.D., D.N.P.) preferred. Key skills include excellent written and verbal communication, ability to work independently and remotely with strong teamwork, strategic thinking, and experience building relationships with stakeholders.

What is the work environment like for this MSL role?

This is a remote, fast-paced position requiring extensive travel over 60%, independent work with strong teamwork, and flexibility to adapt to changes.

What makes a strong candidate for this Medical Science Liaison position?

Strong candidates have an advanced degree, MSL experience (preferred), live in the Lake Michigan territory, and demonstrate outgoing communication, relationship-building skills, strategic thinking, and adaptability in a fast-paced remote environment.

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters
2004Year Founded
$149.9MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Flexible medical plans
Investment options
Time off
Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
New Prospera Heart features may face slow adoption by healthcare providers.
Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
AI integration enhances accuracy and speed of Natera's cfDNA analysis.
Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI